Peripheral Arterial Disease in a Female Using High-dose Combined Oral Contraceptive Pills
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The association between oral contraceptive (OC) pills and vascular diseases is well-known, although, the present generation of pills is considered to be relatively safer in this regard. Hormonal treatment for severe abnormal uterine bleeding is usually considered after ruling out malignancy, when such bleeding is resistant to all other forms of treatment. We report a case of severe peripheral arterial disease in a female, who had been on high-dose OC pills for an extended period of time for severe uterine bleeding.
References
1.
Kluft C, Lansink M
. Effect of oral contraceptives on haemostasis variables. Thromb Haemost. 1997; 78(1):315-26.
View
2.
Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E
. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-45.
DOI: 10.1038/clpt.1981.154.
View
3.
Hsia J, Simon J, Lin F, Applegate W, Vogt M, Hunninghake D
. Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study. Circulation. 2000; 102(18):2228-32.
DOI: 10.1161/01.cir.102.18.2228.
View
4.
De Bruijn S, Stam J, Vandenbroucke J
. Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group. Lancet. 1998; 351(9113):1404.
DOI: 10.1016/s0140-6736(05)79442-3.
View
5.
Baillargeon J, McClish D, Essah P, Nestler J
. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab. 2005; 90(7):3863-70.
DOI: 10.1210/jc.2004-1958.
View